Bullish Signal: SEBI Greenlights Deepa Jewellers, Cotec Healthcare

SEBI has granted approval for the Initial Public Offerings (IPOs) of Deepa Jewellers and Cotec Healthcare. Deepa Jewellers, a B2B hallmarked gold jewellery processor, plans a Rs 250 crore fresh issue along with an offer for sale, while Cotec Healthcare operates as a pharmaceutical CDMO.

This development is significant as it indicates a robust primary market in India, offering new investment avenues for retail and institutional investors. The entry of new players, especially in specialized segments like B2B hallmarked jewellery and pharma CDMO, reflects confidence in India's economic growth trajectory and sector-specific potential.

While no existing listed stocks are directly impacted, the successful listing of these companies could draw investor attention to their respective sectors. A strong debut for Cotec Healthcare might positively influence sentiment towards other Indian pharmaceutical contract manufacturing companies, while Deepa Jewellers' listing could shed light on the valuation appetite for organized jewellery players.

Traders should closely watch for the announcement of IPO dates, price bands, and subscription figures for both Deepa Jewellers and Cotec Healthcare. The grey market premium (GMP) will also be a key indicator of investor interest and potential listing performance. Evaluate the company fundamentals and sector outlook before considering participation.

• •Deepa Jewellers and Cotec Healthcare received SEBI approval for their IPOs.
• •Deepa Jewellers is a B2B hallmarked gold jewellery processor based in Hyderabad.
• •Cotec Healthcare is a pharmaceutical CDMO.
• •Deepa Jewellers' IPO includes a Rs 250 crore fresh issue and an offer for sale by promoters.
• •Risk flag: Overvaluation during IPO due to high market sentiment